...及肾素-血管紧张素系统的影响 时期血浆内皮素(endothelin,ET)、血管紧张素Ⅱ(angioten sin Ⅱ,AT-Ⅱ)及肾素活性(renin activity,RA)的变化,为该药治疗不稳定型心绞痛提供理论依据.
基于66个网页-相关网页
Plasma renin activity (PRA) and Ang Ⅱin 2 groups statistically reduced (P<0.05) and LVEF in 2 groups statistically significantly increased (P<0.01) after treatment. LVESD and LVESV in carvedilol group statistically decreased (P<0.05) after treatment.
2组于治疗后血浆肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)浓度较治疗前降低(P<0.05),左室射血分数增加(P<0.01)。
参考来源 - 长期应用美托洛尔和卡维地洛联合血管紧张素转换酶抑制剂对心肌梗死患者左室重构及心功能的影响·2,447,543篇论文数据，部分数据来源于NoteExpress
肾组织肾素活性在3个观察组间差异无显著性。
The renal rennin activity showed no significant difference among 3 groups.
未证实血游离钙或肾素活性和降压幅度之间存在联系。
The link between blood free calcium or PRA and the depressive effect of indapamide was not ascertained.
当联合使用一种ACE抑制剂时，血浆肾素活性增强是如此之大。
When you combine an ACE inhibitor b, the plasma renin activity increases so much.
应用推荐